President Donald Trump vowed a $100 million investment to revive a Winchester drug manufacturing plant if Republicans win the midterms, putting factory jobs on the November ballot.
Speaking Saturday at Truist Arena on Northern Kentucky University’s campus in Highland Heights, Trump told the crowd the money would go to pharmaceutical company Antheia if Republicans prevail. Newsweek reported his pledge centered on revitalizing what he called a gigantic drug manufacturing facility in Winchester, Kentucky.
“If the Republicans win, the Department of War will be investing $100 million in the pharmaceutical company Antheia to revitalize [a] gigantic drug manufacturing facility in Winchester, Kentucky,” Trump said. “That’s a big one.”
"If the Republicans win, the Department of War will be investing $100 million in the pharmaceutical company Antheia to revitalize [a] gigantic drug manufacturing facility in Winchester, Kentucky," "That's a big one."
The pledge landed as Trump made manufacturing and the economy the core of his Kentucky pitch ahead of the November 3 election. Domestic production of critical pharmaceutical ingredients has already drawn federal attention. The structure, timing, and current status of the proposed Winchester investment have not been laid out in public detail.
Antheia is a California-based manufacturer of key starting materials and active pharmaceutical ingredients. The company announced its first commercial delivery of thebaine in 2024 and is also developing oripavine and scopolamine.
In March, the Department of Health and Human Services’ Administration for Strategic Preparedness and Response announced a $9 million award to Antheia to expand domestic thebaine production. Officials cited foreign supply-chain vulnerability as the reason.
Antheia had earlier received a government-backed project agreement valued at up to $12 million through a program funded by HHS’ Defense Production Act Title III effort. Trump’s Saturday remarks framed the new $100 million figure as a larger next step tied to Republican success at the ballot box. Newsweek sought comment from Antheia.
Trump also projected a fast ramp-up once the plants move.
"Those plants are going to be opening in a year, and when they open you're going to see numbers that nobody's ever seen before,"
He told the Highland Heights crowd the work would not drag on. “It’s going to end very quickly,” he said.
Trump used the stop to boost Republican candidates across the state. Senate candidate Andy Barr was expected at the event as he runs against Democrat Charles Booker for the open seat left by longtime Republican Sen. Mitch McConnell, who is not seeking another term.
A Global Strategy Group poll released by Booker’s campaign showed Barr ahead 49% to 40% among 600 likely Kentucky voters. That survey ran August 24 to 27 and carried a margin of error of plus or minus 4 points.
In the 4th Congressional District, Trump-backed Ed Gallrein defeated incumbent Republican Rep. Thomas Massie in the GOP primary. Gallrein now faces Democrat Melissa Strange. Recent public polling for that matchup was not available in the reporting.
In the open 6th District, Republican Ralph Alvarado faces Democrat Zach Dembo. A Change Research poll conducted online September 29 to October 5 for Kentuckians Not Corruption, an entity the New York Times has described as affiliated with Dembo, showed Dembo at 47%, Alvarado at 38%, and 8% undecided among 524 likely voters. The margin of error was plus or minus 4.4 points.
Trump mixed the economic pitch with foreign policy. On Iran, he offered a blunt assessment of recent U.S. action.
"When I did the little excursion to the beautiful Islamic Republic of Iran, we beat the s*** out of 'em."
On Venezuela, he claimed large financial results. “You know how much money we’re taking out of Venezuela? Hundreds of billions of dollars we’re taking out of Venezuela,” he said.
A protester briefly interrupted the rally and was removed by security. Trump accused the person of being a paid protester receiving $250 and weighed whether charges made sense.
"We shouldn't ruin his life and press charges, right? Just let him go,"
When the crowd pushed back, he answered, “Oh, no? Let’s think about it.” He also asked whether the person was friend or foe, adding that being a foe in that arena “can be a very dangerous thing.” No final charging decision appeared in the account.
Trump’s Kentucky message joined two themes voters can measure. First, rebuild drug manufacturing on American soil after years of foreign dependence. Second, condition a concrete $100 million facility push on Republican wins in November.
Antheia already holds earlier HHS awards totaling millions for thebaine and related work. The Winchester plant Trump described would mark a far larger commitment. Details on deal structure and the facility’s present condition remain unsettled in public records so far.
For Kentucky workers and taxpayers, the choice on November 3 now carries a stated price tag and a stated location. Winchester is on the map. The investment is on the table. The condition is Republican victory.
Voters who want factories and medicine made here finally have a president willing to put real money, and real terms, behind the promise.
